Martin Welschof, Opsona:
"Inventages had the vision and courage to support Opsona's quest to develop first in class and revolutionary treatment option targeting key structures of the innate immune system. ..."

Arvind Sridharan, Horizon:
"Inventages has set itself high standards - and naturally expects the same from its portfolio companies. ..."

Geoff Allison, Tanfield Foods:
"Inventages, since the outset have actively encouraged and supported our growth plans. ..."

Pierre Peteuil, Cryolog:
"Inventages invests in a long term strategy necessary for innovation. ..."

Sven Thormahlen, Mucovax:
"At Inventages people share our passion for the development of our innovative products. ..."

Holger Kunze, Accera:
"Working with Inventages has been very productive. ..."

Paul Hartung, Neuroptix:
"Inventages has been a strong supporter in realizing the Neuroptix vision. ..."

Neill Moray Mackenzie, CMP Therapeutics:
"Inventages has been extremely supportive of CMP Therapeutics since its inception. ..."

Yan Hervy, Velle Russia:
"Over the last year of cooperation, Inventages - through the very high caliber of its associates - has been able to challenge positively Velle Russia business from marketing vision to operational ..."

Graham Clarke, ImmunoBiology:
"Investment capital is of course central to create a valuable business but to be successful you need more than just funds from your investors. ..."

Wren Zhang, GC-Rise:
"GC-Rise has received great support and professional help from Inventages since the beginning. ..."

Erik van den Berg, AM-Pharma:
"Inventages has a broad network of excellent service providers and experts and can provide board room access with potential strategic partners. ..."

Jay Garnett, Steaz:
"Inventages has provided 'smart' capital to Steaz. ..."

Daniel Green, Phagenesis:
"Inventages brings talent, imagination and rigor to the process of identifying suitable investments. ..."

Barry Guld, MSI:
"The team at Inventages is the perfect partner for us. ..."